TherapeuticsMD, Inc. — Director's Dealing 2012

Dec 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2012-11-30

Reporting Person: Cartwright Daniel A (CFO, VP Finance, Treasurer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-10-21	Non-qualified stock option	$.38	A	300000	Acquired	2021-10-21	Common Stock (300000)	Direct
2011-10-21	Warrant	$.38	A	600000	Acquired	2021-10-21	Common Stock (600000)	Direct
2012-11-30	Non-qualified stock option	$3.00	A	700000	Acquired	2022-11-30	Common Stock (700000)	Direct

Footnotes

F1: Option vests annually over a 48-month period. Warrant vests monthly over a 44-month period.

F2: The shares available for purchase under the 11/30/12 option vest at the rate of 233,333 on 11/8/13, 233,333 on 11/8/14 and 233,334 on 11/8/15.